CCM
Consonance Capital Management Portfolio holdings
AUM
$7.28M
This Quarter Return
-8.93%
1 Year Return
-42.86%
3 Year Return
+319.33%
5 Year Return
+899.35%
10 Year Return
–
AUM
$1.34B
AUM Growth
+$1.34B
(-18%)
Cap. Flow
-$63.2M
Cap. Flow
% of AUM
-4.7%
Top 10 Holdings %
Top 10 Hldgs %
61.63%
Holding
43
New
8
Increased
12
Reduced
9
Closed
12
Top Buys
| 1 |
Akebia Therapeutics
AKBA
|
$54M |
| 2 |
Sarepta Therapeutics
SRPT
|
$45.7M |
| 3 |
PRNB
Principia Biopharma Inc. Common Stock
PRNB
|
$41M |
| 4 |
United Therapeutics
UTHR
|
$40.9M |
| 5 |
Cytokinetics
CYTK
|
$40.5M |
Top Sells
| 1 |
ARQL
Arqule Inc
ARQL
|
$134M |
| 2 |
Align Technology
ALGN
|
$75.1M |
| 3 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$63.2M |
| 4 |
Exact Sciences
EXAS
|
$53.6M |
| 5 |
Iovance Biotherapeutics
IOVA
|
$41.8M |
Sector Composition
| 1 | Healthcare | 90.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Karyopharm Therapeutics
KPTI
$61.7M
| $138M | 10.27% | 7,180,700 +1,053,266 | +17% | +$20.2M |
|
|
2
United Therapeutics
UTHR
$13.8B
| $128M | 9.53% | 1,350,360 +431,097 | +47% | +$40.9M |
|
3
Aurinia Pharmaceuticals
AUPH
$1.58B
| $100M | 7.47% | 6,909,374 +283,703 | +4% | +$4.12M |
|
|
CCXI
4
DELISTED
ChemoCentryx, Inc.
CCXI
| $92.3M | 6.87% | 2,297,779 +396,112 | +21% | +$15.9M |
|
|
5
Sarepta Therapeutics
SRPT
$1.78B
| $80.5M | 6% | 823,165 +467,020 | +131% | +$45.7M |
|
|
KDMN
6
DELISTED
Kadmon Holdings, Inc.
KDMN
| $65.4M | 4.87% | 15,608,948 -33,116 | -0.2% | -$139K |
|
7
Omeros
OMER
$283M
| $59.9M | 4.46% | 4,479,872 +1,284,076 | +40% | +$17.2M |
|
8
CareDx
CDNA
$727M
| $58.1M | 4.33% | 2,660,716 +538,740 | +25% | +$11.8M |
|
|
9
Akebia Therapeutics
AKBA
$833M
| $54M | 4.02% | +7,121,283 | New | +$54M |
|
|
EPZM
10
DELISTED
Epizyme, Inc
EPZM
| $51.3M | 3.82% | 3,304,918 -1,001,657 | -23% | -$15.5M |
|
11
uniQure
QURE
$896M
| $49M | 3.65% | 1,032,636 +103,600 | +11% | +$4.92M |
|
12
Assembly Biosciences
ASMB
$190M
| $47.1M | 3.51% | 3,175,535 +1,297,140 | +69% | +$19.2M |
|
|
PRNB
13
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $41M | 3.05% | +689,718 | New | +$41M |
|
|
14
Cytokinetics
CYTK
$4.23B
| $40.5M | 3.01% | +3,432,232 | New | +$40.5M |
|
15
Axogen
AXGN
$743M
| $37.1M | 2.76% | 3,566,054 +579,668 | +19% | +$6.03M |
|
16
Kiniksa Pharmaceuticals
KNSA
$2.48B
| $34.7M | 2.58% | +2,240,779 | New | +$34.7M |
|
|
APTO
17
DELISTED
Aptose Biosciences, Inc.
APTO
| $34.4M | 2.56% | 5,796,482 +1,024,292 | +21% | +$6.08M |
|
18
Travere Therapeutics
TVTX
$1.56B
| $33.8M | 2.51% | 2,314,421 | – | – |
|
19
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $32.8M | 2.44% | +2,020,002 | New | +$32.8M |
|
20
Krystal Biotech
KRYS
$4.27B
| $28.3M | 2.11% | 654,586 +450,798 | +221% | +$19.5M |
|
|
ITCI
21
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $25.4M | 1.89% | 1,654,600 -320,400 | -16% | -$4.92M |
|
22
Xenon Pharmaceuticals
XENE
$2.98B
| $22.4M | 1.67% | +1,979,669 | New | +$22.4M |
|
|
LMNL
23
DELISTED
Liminal BioSciences Inc. Common Shares
LMNL
| $22M | 1.64% | 3,287,311 | – | – |
|
|
BLU
24
DELISTED
BELLUS Health Inc.
BLU
| $15.9M | 1.19% | +1,597,503 | New | +$15.9M |
|
|
OXFD
25
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $11.5M | 0.86% | 1,244,460 -1,119,264 | -47% | -$10.4M |
|